P Malfertheiner – författare

John Libbey Eurotext continues to publish the proceedings of the gastroenterology seminars taught by leading European specialists and organised by the European Association for Gastroenterology and Endoscopy (EAGE). The aim of the book is to describe major clinical and therapeutic progress observed during 2002: gastrooesophageal reflux disease, inflammatory bowel disease, irritable bowel syndrome, colon cancer, liver cancer.

Gastrointestinal Oncology is an expanding field with important medical, scientific, socio-political and ethical challenges. In the last few years, the discipline has undergone changes in our knowledge of tumour biology, diagnosis and treatment. The rate of progress in some gastrointestinal malignancies as oesophageal adenocarcinoma or malignancies of the rectum is dramatic, in other malignancies as pancreatic carcinoma or not. It is generally accepted that the management of these tumours deserves a multidisciplinary approach. Our current understanding of the management of these tumours is the specific focus of this two-day interdisciplinary Postgraduate Course.

Drug-induced mucosal damage is of immense importance in gastroenterology. It is imperative that clinicians understand how these lesions come about, what the sometimes devastating consequences are and what can be done to prevent or to treat such calamities. Drug-induced damage is bound to increase in the future as the population ages and polypharmacy becomes the rule instead of the exception. Hopes for improvement were shattered when the long term consequences of COX-2 inhibition became available. Is the COX-1/COX-2 concept truly obsolete? Several issues are discussed by European experts in the second part of the book. What the clinician should know about non acid, weakly acid or biliary reflux is discussed in depth. Novel developments of gastrointestinal neuropathies and motor disorders concentrate on IBS, pseudo-obstruction and faecal incontinence. Our surgical colleagues will certainly be interested in novel minimally invasive procedures. Finally all will learn from a critical analysis of novel diagnostic imaging modalities.

"A decade of diagnostic efforts in pancreatic diseases (1985-1995)" The diagnostic access to the pancreas was revolutionized two decades ago by the advent of endoscopic retrograde pancreatography, ultrasound, and com­ puted tomography. The "hidden" organ was made visible by these diagnostic milestones. In a process of slow but continuous evolution, these imaging tech­ niques have been further refined and complemented by nuclear magnetic reso­ nance imaging, and together they provide the standards on which therapeutic decisions depend. Progress has also been made in the functional assessment of the pancreas in various conditions of disease such as acute pancreatitis, chronic pancreatitis, and cancer. New developments in molecular biology also promise more significant achievements in the near future. Ten years ago we gathered a panel of international specialists dedicated to the study and management of pancreatic diseases and invited them to share their experiences with the available diagnostic methods. We have now repeated this process in order to review the past decade of progress in diagnostic procedures in pancreatic disease and to update the current state of expertise and stimulate further developments. The concept of the meeting, held in Magdeburg in December 1995, was to individually analyze the different diagnostic procedures and their specific use in the different disease conditions. The rationale for the interpretation of diagnostic findings is derived from the understanding of basic physiological and pathophysiological events and the resultant morphological alterations.

"A decade of diagnostic efforts in pancreatic diseases (1985-1995)" The diagnostic access to the pancreas was revolutionized two decades ago by the advent of endoscopic retrograde pancreatography, ultrasound, and com­ puted tomography. The "hidden" organ was made visible by these diagnostic milestones. In a process of slow but continuous evolution, these imaging tech­ niques have been further refined and complemented by nuclear magnetic reso­ nance imaging, and together they provide the standards on which therapeutic decisions depend. Progress has also been made in the functional assessment of the pancreas in various conditions of disease such as acute pancreatitis, chronic pancreatitis, and cancer. New developments in molecular biology also promise more significant achievements in the near future. Ten years ago we gathered a panel of international specialists dedicated to the study and management of pancreatic diseases and invited them to share their experiences with the available diagnostic methods. We have now repeated this process in order to review the past decade of progress in diagnostic procedures in pancreatic disease and to update the current state of expertise and stimulate further developments. The concept of the meeting, held in Magdeburg in December 1995, was to individually analyze the different diagnostic procedures and their specific use in the different disease conditions. The rationale for the interpretation of diagnostic findings is derived from the understanding of basic physiological and pathophysiological events and the resultant morphological alterations.

An up-to-date and comprehensive book on all aspects of chronic pancreatitis, including new research and controversial issues.

An up-to-date and comprehensive book on all aspects of chronic pancreatitis, including new research and controversial issues.

This book deals with all aspects of surgery of the pancreas.The leading authorities from all over the world havecontributed tothis volume. Surgery of acute pancreatitis, chronicpancreatitis and pancreatic malignancies is demonstrated.Thisbook defines standards for pancreaticand general surgeons.In addition all aspects of diagnostics, pathophysiology andbasic scientific data with regard to pancreatic disease arepresented.